Bedford Laboratories launches Indomethacin for Injection

Links shared publicly online about this topic.

1,376
total visits

Bedford Laboratories launches Indomethacin for Injection

Bedford Laboratories", a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid

View full resource at news-medical.net

Tags: Children's Health, NSAIDs, Indocin

Most Recently Shared on February 17, 2010 at 5:49 am By:

News-Medical.Net

Bedford Laboratories launches Indomethacin for Injection: Bedford Laboratoriesâ„¢, a division of Ben Venue Laborator... http://bit.ly/bRy07H

2 years ago...

Retweet

Favorite

Bedford Labs Recalls Indomethacin for Injection - ONA

oncologynurseadvisor.com — “Bedford Laboratories has initiated a nationwide voluntary recall of one lot of indomethacin for injection 1mg single-dose vials because it may contain particulate matter.” View full resource at oncologynurseadvisor.com

Most Recently Shared on June 16, 2011 at 2:49 pm By:

OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology

Bedford Labs Recalls Indomethacin for Injection http://goo.gl/fb/qOV5R

10 months ago...

Retweet

Favorite

Bedford Labs Recalls Indomethacin for Injection - MPR

empr.com — “Bedford Laboratories has initiated a nationwide voluntary recall of one lot of indomethacin for injection 1mg single-dose vials because it may contain particulate matter.” View full resource at empr.com

Most Recently Shared on June 16, 2011 at 1:54 pm By:

MPR Medical Publisher

MPR News: Bedford Labs Recalls Indomethacin for Injection: Bedford Laboratories has initiated a nationwide volun... http://bit.ly/l5L9d2

10 months ago...

Retweet

Favorite

Bedford Laboratories launches Dactinomycin for Injection

news-medical.net — “Bedford Laboratories", a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Dactinomycin for Injection USP 500 mcg (0.5 mg) to its comprehensive line of generic oncology products. Dactinomycin was approved earlier this year by the U.S. Food and Drug Administration (FDA) and is AP rated and equivalent to Cosmegen® by Lundbeck Inc. Each single dose vial contains 0.5 mg (500mcg) of dactinomycin and 20 mg of mannitol and is individually boxed.” View full resource at news-medical.net